GH Cancer Research Results
GH, Growth Hormone: Click to Expand ⟱
| Source: |
| Type: |
GH is secreted by the pituitary and also produced locally by many tumors (autocrine/paracrine GH).
Growth hormone signaling is pro-oncogenic when chronically elevated or locally produced by tumors, acting mainly through:
-IGF-1 → PI3K–AKT–mTOR
-JAK2–STAT5
-Angiogenesis and EMT support
It functions as a metabolic growth amplifier, especially in insulin-resistant and obesity-linked cancers.
Interventions (context-dependent):
-Caloric restriction / fasting
-Insulin sensitivity improvement
-mTOR / IGF-1R pathway inhibition (oncology settings)
|
Scientific Papers found: Click to Expand⟱
GH↓, These effects of fasting/FMD on normal and cancer cells are mediated at least in part by the reduction in GH and IGF-I signaling.
IGF-1↓,
glucose↓, In mice, cycles of a 4-day FMD have been shown to lower blood glucose levels by 40 % and IGF-I by 45 % while increasing ketone bodies 9-fold and IGFBP-1, which inhibits IGF-I, by the end of the FMD
IGFBP1↑,
OS↑, FMD cycles adopted twice a month starting in middle age extend health span and longevity, reduce visceral fat and skin lesions, promote hippocampal neurogenesis, rejuvenate the immune system, and delay bone mineral density loss in mice
Imm↑,
neuroP↑,
BMD↑,
Dose↝, FMD is a plant-based caloric-restricted dietary regimen (typically between 300 and 1100 kcal per day) characterized by low proteins, sugars, and relatively high unsaturated fats.
Risk↓, Remarkably, these bi-monthly FMD cycles started in middle age reduce tumor incidence and delay cancer onset.
other↑, The robust epidemiological evidence that high animal protein consumption increases serum IGF-I levels in humans
TumCP↓, For these reasons, the GH/IGF-I axis emerged as a promising target for cancer treatments and prevention aimed at inhibiting cell proliferation by down-regulating IGF-I
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
glucose↓, 1,
Transcription & Epigenetics ⓘ
other↑, 1,
Proliferation, Differentiation & Cell State ⓘ
GH↓, 1, IGF-1↓, 1, IGFBP1↑, 1,
Migration ⓘ
TumCP↓, 1,
Immune & Inflammatory Signaling ⓘ
Imm↑, 1,
Drug Metabolism & Resistance ⓘ
Dose↝, 1,
Clinical Biomarkers ⓘ
BMD↑, 1,
Functional Outcomes ⓘ
neuroP↑, 1, OS↑, 1, Risk↓, 1,
Total Targets: 12
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: GH, Growth Hormone
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1426 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page